Drug manufacturer Eli Lilly yesterday responded to the federal government’s June 25 motion to a federal judge in Indianapolis to dismiss the company’s case challenging the legality and constitutionality of the government’s 340B contract pharmacy requirements and 340B administrative dispute resolution (ADR) process.
U.S. District Judge Sarah Evans Barker is scheduled to hear arguments in the case on July 30. In March, Barker enjoined the U.S. Health Resources and Services Administration (HRSA) from enforcing its ADR regulations against Lilly, saying the company was likely to ultimately win its argument that HHS violated procedural requirements when it finalized the ADR rule.
Drug manufacturer Eli Lilly yesterday responded to the federal government’s June 25 motion to a federal judge in Indianapolis to dismiss the company’s case challenging the legality and constitutionality of the government’s 340B contract pharmacy requirements and 340B administrative dispute resolution (ADR) process.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.